_id
6911c2f2ccc777a4e85d6442
Ticker
HBMHF
Name
HBM Holdings Limited
Exchange
PINK
Address
Building A3, Suzhou, China, 215123
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.harbourbiomed.com
Description
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds and inhibits the neonatal fragment crystallizable receptor for treating myasthenia gravis; Porustobart HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4 for treating melanoma, colorectal cancer, hepatocellular carcinoma, and neuroendocrine neoplasm. It is also developing HBM7020 for treating hematologic carcinoma and autoimmune diseases; HBM9378 for the treatment of asthma and chronic obstructive pulmonary disease; and HBM1020, HBM1022, HBM9014, HBM7022, HBM7008, HBM9027, HBM7004, and HBM9033 for treating solid tumors. The company has a strategic collaboration with Evinova to apply AI and digital technologies to enhance the efficiency of biologics development. The company was incorporated in 2016 and is based in Suzhou, the People's Republic of China.
Last Close
2.52
Volume
-
Current Price
2.52
Change
0
Last Updated
2026-01-04T14:18:25.091Z
Image
data:image/webp;base64,UklGRtYDAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSM8BAAABkERre6FJb1Bj27Zt27ZnVrbbvZudbdu2bds2212VLCp/KjVa9SIiJgD/jyxbXmWedD6kyJVXncxIjuW3lTeGMXM1jt5WlzGS94RU2pE+NHkj1VX+lMavk8YIp3/atOKlSxXLldZi5A8RHx48ffLgyrENYXVzst8qz3GVZszL/UNKpSTGUuVK5sFq9MCT+/bcGhkMZZp8fGxOqkFyj3xhG5H2uy0dCyQjnqoXW/5TRp3smY2qaLm9sdJ81MnIUqmJnjPtvJBSyqjtdZgrWc9HQvqa+PnIsEYFUtEmAUSCVIsNOQEkG/RW+i8+X9g2Y/E3lebTigBSB0VJbWddrZIlKrcdufzEB6HjFkJ6vVqDAMmGf5T6diQnhFCWLHfjKZd+OVqenesNKEC7/5CeGAKyjM3nPXKMxW4vTQEUOyvVUT8NADRV1XFXfhhJfDM+DwGA1N1PxLneBZ01AoDlG7jzs7ePi+smg5rlHXwxRt7umv+4KYBnahJy/lW00JndODWBJi829WALK+8JcwCSFawXtHLX5bgA1eCVWQQ+AaDcavomQBVPbv8ANH6dpEmeY7YyPsKPl7baTNo+QVPck+tScwVGTlEG5VQQzjnX+G8HAFZQOCDgAQAA8A0AnQEqQABAAD61TqFLpyQjIawVWzDgFolsALyiAX5n1mFAOj8bfxXG1ep8seLn1AflreAeYD7Vfex9AH+R9OD0h/UA9ADpQ3Rgoo1fXlxJZqxl9bt5zMp7C5fCPjGjeaa0eJ8GAsPpo0JnbQuquJNVl6/ROoNQAP752n//SBU8bI6Ylj0puK3/vdM3PH4NenodjMNbT/If/ZdBYmeH0ti+HEmbIWdnefoG9tG7ooEpF5p9Jv/mN//eQEXrOn2acHk6xTXRkrZbD2SCO0Z3lxWSOGpcucVN4u3w1YqJ5hS5x48IvMu8sAB09TjansG9tdCWI4RcuQg5kzps4BEPDzgX9P88aiaNfimJ7QntyE/WDeVcrSAnNwapYIN5X7UHcDAULp6mrytdDSHs4AOMzwXWz1m7bfmg7+GkqQ5BbOq+V/osWJr6Q/CtYSy60d8ljVMEE57X9EedfuRT+ue6zkyy/6wcyD3asnvs/iTwo6axGPvTfgZ3tldNjGMTUfh5U2LO/17k3fK29lvXax4kCT4cvrz83Fn5yrGULjzbHapghmxVGnirmdhLEdiDDymFB1dftiMAAhOgD4li4/IeWNjVGJj6V9PVCssS0wjRewhALULAblxp1Tt//vBrgAAA
Ipo Date
-
Market Cap
2107642624
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.991
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
101315000
Cost Of Revenue
4855000
Gross Profit
96460000
Operating Expenses
28188000
Operating Income
68272000
Interest Expense
800864
Pretax Income
73567000
Net Income
71718000
Eps
0.09156905065983993
Dividends Per Share
-
Shares Outstanding
836366162
Income Tax Expense
568000
EBITDA
68768000
Operating Margin
67.38587573409663
Total Other Income Expense Net
5295000
Cash
320687000
Short Term Investments
-
Receivables
5619000
Inventories
1964000
Total Current Assets
349874000
Property Plant Equipment
4476000
Total Assets
380474000
Payables
5460000
Short Term Debt
42648999
Long Term Debt
19935000
Total Liabilities
96892000
Equity
282695999
Bs_currency_symbol
USD
Depreciation
1046000
Change In Working Capital
-162000
Cash From Operations
64686403
Capital Expenditures
320000
Cash From Investing
-397951
Cash From Financing
88385000
Net Change In Cash
320687000
Cf_currency_symbol
-
PE
28
PB
6.981686392809542
ROE
25.369301388662386
ROA
18.849645442264123
FCF
64366403
Fcf Percent
0.635309707348369
Piotroski FScore
3
Health Score
85
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
10
Garp Investing Score
10
Growth Investing Score
8.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
10
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
101315000
Quarters > 0 > income Statement > cost Of Revenue
4855000
Quarters > 0 > income Statement > gross Profit
96460000
Quarters > 0 > income Statement > operating Expenses
28188000
Quarters > 0 > income Statement > operating Income
68272000
Quarters > 0 > income Statement > interest Expense
800864
Quarters > 0 > income Statement > pretax Income
73567000
Quarters > 0 > income Statement > net Income
71718000
Quarters > 0 > income Statement > eps
0.09156905065983993
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
783212226
Quarters > 0 > income Statement > income Tax Expense
568000
Quarters > 0 > income Statement > EBITDA
68768000
Quarters > 0 > income Statement > operating Margin
67.38587573409663
Quarters > 0 > income Statement > total Other Income Expense Net
5295000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
320687000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5619000
Quarters > 0 > balance Sheet > inventories
1964000
Quarters > 0 > balance Sheet > total Current Assets
349874000
Quarters > 0 > balance Sheet > property Plant Equipment
4476000
Quarters > 0 > balance Sheet > total Assets
380474000
Quarters > 0 > balance Sheet > payables
5460000
Quarters > 0 > balance Sheet > short Term Debt
42648999
Quarters > 0 > balance Sheet > long Term Debt
19935000
Quarters > 0 > balance Sheet > total Liabilities
96892000
Quarters > 0 > balance Sheet > equity
282695999
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
71718000
Quarters > 0 > cash Flow > depreciation
1046000
Quarters > 0 > cash Flow > change In Working Capital
-162000
Quarters > 0 > cash Flow > cash From Operations
64686403
Quarters > 0 > cash Flow > capital Expenditures
320000
Quarters > 0 > cash Flow > cash From Investing
-397951
Quarters > 0 > cash Flow > cash From Financing
88385000
Quarters > 0 > cash Flow > net Change In Cash
320687000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.09156905065983993
Quarters > 0 > ratios > PB
6.981686392809542
Quarters > 0 > ratios > ROE
25.369301388662386
Quarters > 0 > ratios > ROA
18.849645442264123
Quarters > 0 > ratios > FCF
64366403
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.635309707348369
Quarters > 0 > health Score
85
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
14428572
Quarters > 1 > income Statement > cost Of Revenue
4425069
Quarters > 1 > income Statement > gross Profit
10003503
Quarters > 1 > income Statement > operating Expenses
13500670
Quarters > 1 > income Statement > operating Income
-3497167
Quarters > 1 > income Statement > interest Expense
1949996
Quarters > 1 > income Statement > pretax Income
2019138
Quarters > 1 > income Statement > net Income
1356780
Quarters > 1 > income Statement > eps
0.0016728427052382009
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
811062508
Quarters > 1 > income Statement > income Tax Expense
671376
Quarters > 1 > income Statement > EBITDA
5086425
Quarters > 1 > income Statement > operating Margin
-24.23779012919643
Quarters > 1 > income Statement > total Other Income Expense Net
5516305
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
166821000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
21134000
Quarters > 1 > balance Sheet > inventories
2373000
Quarters > 1 > balance Sheet > total Current Assets
196095000
Quarters > 1 > balance Sheet > property Plant Equipment
3584493
Quarters > 1 > balance Sheet > total Assets
215014000
Quarters > 1 > balance Sheet > payables
5254000
Quarters > 1 > balance Sheet > short Term Debt
56610000
Quarters > 1 > balance Sheet > long Term Debt
3862000
Quarters > 1 > balance Sheet > total Liabilities
90962000
Quarters > 1 > balance Sheet > equity
124447000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
1356780
Quarters > 1 > cash Flow > depreciation
1117289
Quarters > 1 > cash Flow > change In Working Capital
-10993697
Quarters > 1 > cash Flow > cash From Operations
-9881426
Quarters > 1 > cash Flow > capital Expenditures
91830
Quarters > 1 > cash Flow > cash From Investing
-134895
Quarters > 1 > cash Flow > cash From Financing
-6727522
Quarters > 1 > cash Flow > net Change In Cash
-15979580
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.0016728427052382009
Quarters > 1 > ratios > PB
16.423678515030495
Quarters > 1 > ratios > ROE
1.090247253851037
Quarters > 1 > ratios > ROA
0.6310193754825267
Quarters > 1 > ratios > FCF
-9973256
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.691215735001357
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
23701000
Quarters > 2 > income Statement > cost Of Revenue
1185000
Quarters > 2 > income Statement > gross Profit
22516000
Quarters > 2 > income Statement > operating Expenses
22721000
Quarters > 2 > income Statement > operating Income
-205000
Quarters > 2 > income Statement > interest Expense
1560686
Quarters > 2 > income Statement > pretax Income
1724000
Quarters > 2 > income Statement > net Income
1424000
Quarters > 2 > income Statement > eps
0.001926902973585573
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
739009706
Quarters > 2 > income Statement > income Tax Expense
327000
Quarters > 2 > income Statement > EBITDA
5058464
Quarters > 2 > income Statement > operating Margin
-0.8649424074933546
Quarters > 2 > income Statement > total Other Income Expense Net
1929000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
183038000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1471000
Quarters > 2 > balance Sheet > inventories
616000
Quarters > 2 > balance Sheet > total Current Assets
202891000
Quarters > 2 > balance Sheet > property Plant Equipment
3470546
Quarters > 2 > balance Sheet > total Assets
219706000
Quarters > 2 > balance Sheet > payables
5382000
Quarters > 2 > balance Sheet > short Term Debt
44226000
Quarters > 2 > balance Sheet > long Term Debt
21424000
Quarters > 2 > balance Sheet > total Liabilities
96899000
Quarters > 2 > balance Sheet > equity
123193000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1425540
Quarters > 2 > cash Flow > depreciation
1771914
Quarters > 2 > cash Flow > change In Working Capital
50173000
Quarters > 2 > cash Flow > cash From Operations
43730242
Quarters > 2 > cash Flow > capital Expenditures
174186
Quarters > 2 > cash Flow > cash From Investing
-93100
Quarters > 2 > cash Flow > cash From Financing
-65070
Quarters > 2 > cash Flow > net Change In Cash
42672366
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.001926902973585573
Quarters > 2 > ratios > PB
15.116966541280755
Quarters > 2 > ratios > ROE
1.1559098325391866
Quarters > 2 > ratios > ROA
0.6481388764985936
Quarters > 2 > ratios > FCF
43556056
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
1.8377307286612379
Quarters > 2 > health Score
59
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
11850500
Quarters > 3 > income Statement > cost Of Revenue
592500
Quarters > 3 > income Statement > gross Profit
11258000
Quarters > 3 > income Statement > operating Expenses
11360500
Quarters > 3 > income Statement > operating Income
-102500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
862000
Quarters > 3 > income Statement > net Income
712000
Quarters > 3 > income Statement > eps
0.0009634514867927865
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
739009706
Quarters > 3 > income Statement > income Tax Expense
163500
Quarters > 3 > income Statement > EBITDA
496000
Quarters > 3 > income Statement > operating Margin
-0.8649424074933546
Quarters > 3 > income Statement > total Other Income Expense Net
964500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
183038000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1471000
Quarters > 3 > balance Sheet > inventories
616000
Quarters > 3 > balance Sheet > total Current Assets
202891000
Quarters > 3 > balance Sheet > property Plant Equipment
3472000
Quarters > 3 > balance Sheet > total Assets
219706000
Quarters > 3 > balance Sheet > payables
5382000
Quarters > 3 > balance Sheet > short Term Debt
44226000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
96899000
Quarters > 3 > balance Sheet > equity
123193000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
712000
Quarters > 3 > cash Flow > depreciation
885000
Quarters > 3 > cash Flow > change In Working Capital
25086500
Quarters > 3 > cash Flow > cash From Operations
21040000
Quarters > 3 > cash Flow > capital Expenditures
43500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-801000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.0009634514867927865
Quarters > 3 > ratios > PB
15.116966541280755
Quarters > 3 > ratios > ROE
0.5779549162695933
Quarters > 3 > ratios > ROA
0.3240694382492968
Quarters > 3 > ratios > FCF
20996500
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
1.7717817813594363
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
38100000
Annuals > 0 > income Statement > cost Of Revenue
4486000
Annuals > 0 > income Statement > gross Profit
33614000
Annuals > 0 > income Statement > operating Expenses
35799000
Annuals > 0 > income Statement > operating Income
-2185000
Annuals > 0 > income Statement > interest Expense
3505000
Annuals > 0 > income Statement > pretax Income
3739000
Annuals > 0 > income Statement > net Income
2778000
Annuals > 0 > income Statement > eps
0.0035963180755728625
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
772456702
Annuals > 0 > income Statement > income Tax Expense
997000
Annuals > 0 > income Statement > EBITDA
10170377
Annuals > 0 > income Statement > operating Margin
-5.7349081364829395
Annuals > 0 > income Statement > total Other Income Expense Net
7433999
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
166821000
Annuals > 0 > balance Sheet > short Term Investments
399000
Annuals > 0 > balance Sheet > receivables
21134000
Annuals > 0 > balance Sheet > inventories
2373000
Annuals > 0 > balance Sheet > total Current Assets
196095000
Annuals > 0 > balance Sheet > property Plant Equipment
3584493
Annuals > 0 > balance Sheet > total Assets
215014000
Annuals > 0 > balance Sheet > payables
5254000
Annuals > 0 > balance Sheet > short Term Debt
56610000
Annuals > 0 > balance Sheet > long Term Debt
3862000
Annuals > 0 > balance Sheet > total Liabilities
90962000
Annuals > 0 > balance Sheet > equity
124447000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
3739000
Annuals > 0 > cash Flow > depreciation
2885000
Annuals > 0 > cash Flow > change In Working Capital
29217000
Annuals > 0 > cash Flow > cash From Operations
30676000
Annuals > 0 > cash Flow > capital Expenditures
235000
Annuals > 0 > cash Flow > cash From Investing
6555000
Annuals > 0 > cash Flow > cash From Financing
-10237000
Annuals > 0 > cash Flow > net Change In Cash
26497000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.0035963180755728625
Annuals > 0 > ratios > PB
15.641926997356304
Annuals > 0 > ratios > ROE
2.232275587197763
Annuals > 0 > ratios > ROA
1.292008892444213
Annuals > 0 > ratios > FCF
30441000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.7989763779527559
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
89502000
Annuals > 1 > income Statement > cost Of Revenue
2034000
Annuals > 1 > income Statement > gross Profit
87468000
Annuals > 1 > income Statement > operating Expenses
65641000
Annuals > 1 > income Statement > operating Income
21827000
Annuals > 1 > income Statement > interest Expense
3872000
Annuals > 1 > income Statement > pretax Income
22682000
Annuals > 1 > income Statement > net Income
22797000
Annuals > 1 > income Statement > eps
0.030701789413198264
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
742530010
Annuals > 1 > income Statement > income Tax Expense
-81000
Annuals > 1 > income Statement > EBITDA
31257957
Annuals > 1 > income Statement > operating Margin
24.387164532636145
Annuals > 1 > income Statement > total Other Income Expense Net
855000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
140324000
Annuals > 1 > balance Sheet > short Term Investments
401000
Annuals > 1 > balance Sheet > receivables
65256288
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
210176000
Annuals > 1 > balance Sheet > property Plant Equipment
4879000
Annuals > 1 > balance Sheet > total Assets
228480000
Annuals > 1 > balance Sheet > payables
15363000
Annuals > 1 > balance Sheet > short Term Debt
37434000
Annuals > 1 > balance Sheet > long Term Debt
27847000
Annuals > 1 > balance Sheet > total Liabilities
108851000
Annuals > 1 > balance Sheet > equity
119988000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
22682000
Annuals > 1 > cash Flow > depreciation
4631000
Annuals > 1 > cash Flow > change In Working Capital
-50416000
Annuals > 1 > cash Flow > cash From Operations
-19122000
Annuals > 1 > cash Flow > capital Expenditures
2480000
Annuals > 1 > cash Flow > cash From Investing
28087000
Annuals > 1 > cash Flow > cash From Financing
-29143000
Annuals > 1 > cash Flow > net Change In Cash
-21381000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.030701789413198264
Annuals > 1 > ratios > PB
15.594689678967896
Annuals > 1 > ratios > ROE
18.999399939994
Annuals > 1 > ratios > ROA
9.977678571428573
Annuals > 1 > ratios > FCF
-21602000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.24135773502268107
Annuals > 1 > health Score
61
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
40755805
Annuals > 2 > income Statement > cost Of Revenue
8184440
Annuals > 2 > income Statement > gross Profit
32571365
Annuals > 2 > income Statement > operating Expenses
154749570
Annuals > 2 > income Statement > operating Income
-122178204
Annuals > 2 > income Statement > interest Expense
1991730
Annuals > 2 > income Statement > pretax Income
-137346233
Annuals > 2 > income Statement > net Income
-137548714
Annuals > 2 > income Statement > eps
-0.18856878949633699
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
729435207
Annuals > 2 > income Statement > income Tax Expense
248590
Annuals > 2 > income Statement > EBITDA
-127300371
Annuals > 2 > income Statement > operating Margin
-299.781108482583
Annuals > 2 > income Statement > total Other Income Expense Net
-15168028
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
162223760
Annuals > 2 > balance Sheet > short Term Investments
9991116
Annuals > 2 > balance Sheet > receivables
28126991
Annuals > 2 > balance Sheet > inventories
1043072
Annuals > 2 > balance Sheet > total Current Assets
208826324
Annuals > 2 > balance Sheet > property Plant Equipment
7949931
Annuals > 2 > balance Sheet > total Assets
231916793
Annuals > 2 > balance Sheet > payables
22029000
Annuals > 2 > balance Sheet > short Term Debt
42406000
Annuals > 2 > balance Sheet > long Term Debt
47085000
Annuals > 2 > balance Sheet > total Liabilities
139497966
Annuals > 2 > balance Sheet > equity
92743537
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-137548714
Annuals > 2 > cash Flow > depreciation
8054130
Annuals > 2 > cash Flow > change In Working Capital
8128306
Annuals > 2 > cash Flow > cash From Operations
-98746548
Annuals > 2 > cash Flow > capital Expenditures
18481899
Annuals > 2 > cash Flow > cash From Investing
135044766
Annuals > 2 > cash Flow > cash From Financing
70575000
Annuals > 2 > cash Flow > net Change In Cash
105935551
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.18856878949633699
Annuals > 2 > ratios > PB
19.819998040833834
Annuals > 2 > ratios > ROE
-148.31083485634153
Annuals > 2 > ratios > ROA
-59.30951020006559
Annuals > 2 > ratios > FCF
-117228447
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.8763619562906437
Annuals > 2 > health Score
17
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4293830
Annuals > 3 > income Statement > cost Of Revenue
6923154
Annuals > 3 > income Statement > gross Profit
-2629324
Annuals > 3 > income Statement > operating Expenses
139899341
Annuals > 3 > income Statement > operating Income
-142528665
Annuals > 3 > income Statement > interest Expense
175421
Annuals > 3 > income Statement > pretax Income
-137375669
Annuals > 3 > income Statement > net Income
-137323840
Annuals > 3 > income Statement > eps
-0.18750421307741222
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
732377357
Annuals > 3 > income Statement > income Tax Expense
48838
Annuals > 3 > income Statement > EBITDA
-130844000
Annuals > 3 > income Statement > operating Margin
-3319.3830449738343
Annuals > 3 > income Statement > total Other Income Expense Net
5170000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
56288209
Annuals > 3 > balance Sheet > short Term Investments
159955127
Annuals > 3 > balance Sheet > receivables
25992
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
240799448
Annuals > 3 > balance Sheet > property Plant Equipment
19070650
Annuals > 3 > balance Sheet > total Assets
282281811
Annuals > 3 > balance Sheet > payables
25993000
Annuals > 3 > balance Sheet > short Term Debt
3391000
Annuals > 3 > balance Sheet > long Term Debt
11256000
Annuals > 3 > balance Sheet > total Liabilities
59430328
Annuals > 3 > balance Sheet > equity
223130405
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-137323840
Annuals > 3 > cash Flow > depreciation
-6786604
Annuals > 3 > cash Flow > change In Working Capital
221269
Annuals > 3 > cash Flow > cash From Operations
-122938311
Annuals > 3 > cash Flow > capital Expenditures
14155288
Annuals > 3 > cash Flow > cash From Investing
-78911597
Annuals > 3 > cash Flow > cash From Financing
1587760
Annuals > 3 > cash Flow > net Change In Cash
-200490000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.18750421307741222
Annuals > 3 > ratios > PB
8.271355665938938
Annuals > 3 > ratios > ROE
-61.54420774703474
Annuals > 3 > ratios > ROA
-48.64778198549959
Annuals > 3 > ratios > FCF
-137093599
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-31.928045358106864
Annuals > 3 > health Score
26
Valuation > metrics > PE
28
Valuation > metrics > PB
6.981686392809542
Valuation > final Score
16.4
Valuation > verdict
72.4% Overvalued
Profitability > metrics > ROE
25.369301388662386
Profitability > metrics > ROA
20.498236508000023
Profitability > metrics > Net Margin
0.7078714899077135
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.342742735456967
Risk > metrics > Interest Coverage
85.24793223318815
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
7.272527121173317
Liquidity > metrics > Quick Ratio
7.23170315807236
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
18
Prev Profitabilities > 1
13
Prev Profitabilities > 2
11
Prev Risks > 0
41
Prev Risks > 1
47
Prev Risks > 2
47
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:57:23.039Z
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds and inhibits the neonatal fragment crystallizable receptor for treating myasthenia gravis; Porustobart HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4 for treating melanoma, colorectal cancer, hepatocellular carcinoma, and neuroendocrine neoplasm. It is also developing HBM7020 for treating hematologic carcinoma and autoimmune diseases; HBM9378 for the treatment of asthma and chronic obstructive pulmonary disease; and HBM1020, HBM1022, HBM9014, HBM7022, HBM7008, HBM9027, HBM7004, and HBM9033 for treating solid tumors. The company has a strategic collaboration with Evinova to apply AI and digital technologies to enhance the efficiency of biologics development. The company was incorporated in 2016 and is based in Suzhou, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of HBM Holdings Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.